Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae-Wook Chun

Showing results (51-60 of 140) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Investigation|February 17, 2026
Characterization of elite controllers with undetectable intact HIV DNA reservoirJana Blazkova, Brooke D Kennedy, Jesse S Justement, et al.
Blood|November 5, 2003
Continuous flow leukapheresis induces expression of stress genes in lymphocytes: impact on microarray analysesSusan Moir, Eileen T Donoghue, Oxana K Pickeral, et al.
The Journal of Infectious Diseases|May 23, 2014
HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatmentKatherine Luzuriaga, Barbara Tabak, Manuel Garber, et al.
The Journal of Infectious Diseases|February 5, 2008
Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV diseaseSusan Moir, Angela Malaspina, Jason Ho, et al.
The Journal of Infectious Diseases|April 6, 2023
Impact of Monkeypox Virus Infection on Immune Parameters in a Woman With Human Immunodeficiency Virus Receiving Clinically Effective Antiretroviral TherapyM Ali Rai, Victoria Shi, Brooke D Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2003
Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individualsSusan Moir, Kisani M Ogwaro, Angela Malaspina, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2020
Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic windowJack L Sloane, Nancy L Benner, Katherine N Keenan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2006
Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanismsJason Ho, Susan Moir, Angela Malaspina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2014
Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral bloodAri Bitnun, Lindy Samson, Tae-Wook Chun, et al.
Bioresearch Open Access|February 11, 2016
A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons LearnedAnn C Collier, Tae-Wook Chun, Janine Maenza, et al.
Pageof 14

Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Investigation|February 17, 2026
Characterization of elite controllers with undetectable intact HIV DNA reservoirJana Blazkova, Brooke D Kennedy, Jesse S Justement, et al.
Blood|November 5, 2003
Continuous flow leukapheresis induces expression of stress genes in lymphocytes: impact on microarray analysesSusan Moir, Eileen T Donoghue, Oxana K Pickeral, et al.
The Journal of Infectious Diseases|May 23, 2014
HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatmentKatherine Luzuriaga, Barbara Tabak, Manuel Garber, et al.
The Journal of Infectious Diseases|February 5, 2008
Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV diseaseSusan Moir, Angela Malaspina, Jason Ho, et al.
The Journal of Infectious Diseases|April 6, 2023
Impact of Monkeypox Virus Infection on Immune Parameters in a Woman With Human Immunodeficiency Virus Receiving Clinically Effective Antiretroviral TherapyM Ali Rai, Victoria Shi, Brooke D Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2003
Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individualsSusan Moir, Kisani M Ogwaro, Angela Malaspina, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2020
Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic windowJack L Sloane, Nancy L Benner, Katherine N Keenan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2006
Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanismsJason Ho, Susan Moir, Angela Malaspina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2014
Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral bloodAri Bitnun, Lindy Samson, Tae-Wook Chun, et al.
Bioresearch Open Access|February 11, 2016
A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons LearnedAnn C Collier, Tae-Wook Chun, Janine Maenza, et al.
Pageof 14